Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01716325
Other study ID # EHOW
Secondary ID
Status Recruiting
Phase N/A
First received October 24, 2012
Last updated October 24, 2012
Start date February 2012
Est. completion date April 2013

Study information

Verified date October 2012
Source University of Primorska
Contact Cirila Hlastan Ribic, PhD, Prof.
Phone +386 1 5477372
Email cirila.hlastan@ivz-rs.si
Is FDA regulated No
Health authority Slovenia: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of the study is to establish and clinically evaluate a new approach to treating obesity by using information and communication technologies (ICT). A mobile environment and organizational interventions to improve the process of an integrated treatment of people with obesity will be identified, developed, introduced and clinically evaluated.


Description:

A mobile environment to improve the process of an integrated treatment of obese people will be identified, developed, introduced and clinically evaluated. The study will include 150 patients aged between 25 to 65 for men and 25 to 70 for women, diagnosed with obesity (BMI≥30 or BMI>27,5 and 20% risk or more for developing a cardiovascular diseases). One group of patients will visit conventional live workshops for weight loss and the other group will use ICT. At the initial examination by the doctor all survey participants will have measured blood pressure, body mass, waist circumference, percentage of body fat, percentage of skeletal muscle, resting metabolic rate, estimated risk of developing cardiovascular disease and will be directed to laboratory examination (blood lipids and cholesterol, blood sugar). Both groups will go through 16 workshops for weight loss. Each week they will monitor their body mass, waist circumference, physical activity (type, duration, intensity) and food intake (type, quantity). After six months all survey participants will be examined again. We will compare effectiveness of ICT weight loss group with conventional weight loss group.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date April 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

- BMI=30 or BMI>27,5 and 20% or more risk for developing a cardiovascular diseases

- Age between 25 - 65 years for men and 25 - 70 years for women

- Own a mobile phone

- Internet

- Know how to use a computer

- Know how to use an e-mail

- Signed voluntary consent to participate in the survey

Exclusion Criteria:

- People with movement disorders

- Age<18 years or age>70 years for women and 65 years for men

- Pregnancy, breast feeding, intention of getting pregnant during the study, period after childbirth (9 months)

- Does not own or know how to handle a mobile phone

- No internet access

- Known hospitalization for severe psychiatric disorders (schizophrenia, psychosis)

- Known history of eating disorders (anorexia, bulimia nervosa and others)

- Cancer incidence in the last 5 years

- Heart problems, chest pain, nausea, dizziness

- Chronic inflammatory diseases

- Other unregulated chronic diseases

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Self-management weight loss plan endorsement.
Self-management weight loss plan endorsement.
Conventional
Weight loss, comparator - no ICT support; conventional live workshops for weight loss

Locations

Country Name City State
Slovenia CINDI Slovenia, National Institute of Public Health Ljubljana

Sponsors (2)

Lead Sponsor Collaborator
University of Primorska National Institute of Public Health, Slovenia

Country where clinical trial is conducted

Slovenia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight loss Weight loss of 5 to 10 % of the body mass at the beginning of the study 16 weeks No
Secondary Successful maintenance or improvement of the following measured parameter: Body mass index. 16 weeks No
Secondary Successful maintenance or improvement of the following measured parameter: waist circumference 16 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2